Avalo Therapeutics (FRA:C6K0) Days Payable : 0.00 (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Avalo Therapeutics Days Payable?

Avalo Therapeutics's average Accounts Payable for the three months ended in Mar. 2024 was €0.63 Mil. Avalo Therapeutics's Cost of Goods Sold for the three months ended in Mar. 2024 was €-0.07 Mil.

The historical rank and industry rank for Avalo Therapeutics's Days Payable or its related term are showing as below:

FRA:C6K0' s Days Payable Range Over the Past 10 Years
Min: 153.67 Med: 567.8 Max: 2829.97
Current: 945.09

During the past 11 years, Avalo Therapeutics's highest Days Payable was 2829.97. The lowest was 153.67. And the median was 567.80.

FRA:C6K0's Days Payable is ranked better than
84.33% of 721 companies
in the Biotechnology industry
Industry Median: 148.28 vs FRA:C6K0: 945.09

Avalo Therapeutics's Days Payable declined from Mar. 2023 (701.56) to Mar. 2024 (0.00). It may suggest that Avalo Therapeutics accelerated paying its suppliers.

Avalo Therapeutics Days Payable Historical Data

The historical data trend for Avalo Therapeutics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avalo Therapeutics Days Payable Chart

Avalo Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

2,945.12

705.37

321.04

485.32

Avalo Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Payable	Get a 7-Day Free Trial															701.56	411.60	282.84	-	-

Competitive Comparison of Avalo Therapeutics's Days Payable

For the Biotechnology subindustry, Avalo Therapeutics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avalo Therapeutics's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avalo Therapeutics's Days Payable distribution charts can be found below:

* The bar in red indicates where Avalo Therapeutics's Days Payable falls into.

Avalo Therapeutics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Avalo Therapeutics's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (2.721	+	0.409)	/	2 )	/	1.177	*	365
=	1.565					/	1.177	*	365
=	485.32

Avalo Therapeutics's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

	Days Payable (Q: Mar. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Mar. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2024 )	*	Days in Period
=	( (0.409	+	0.843)	/	2 )	/	-0.074	*	365 / 4
=	0.626					/	-0.074	*	365 / 4
=	N/A

Avalo Therapeutics Days Payable Related Terms

Thank you for viewing the detailed overview of Avalo Therapeutics's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Avalo Therapeutics (FRA:C6K0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avalo Therapeutics Inc (FRA:C6K0) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

AVTX:USA C6K0:Germany

Address

540 Gaither Road, Suite 400, Rockville, MD, USA, 20850

Website

https://www.avalotx.com

Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing in development with ongoing clinical programs: AVTX-002, AVTX-007, and AVTX-006.

Avalo Therapeutics (FRA:C6K0) Headlines

No Headlines